Day 3 Highlights from ASH 2024: Lymphoma Breakthroughs and Myeloma Insights

Curie: Healthcare in Focus
10/12/2024 5 min Temporada 1 Episodio 5
Day 3 Highlights from ASH 2024: Lymphoma Breakthroughs and Myeloma Insights

Listen "Day 3 Highlights from ASH 2024: Lymphoma Breakthroughs and Myeloma Insights"

Descargar episodio Ver en sitio original

Episode Synopsis

Day 3 of ASH 2024 revealed groundbreaking findings: a 97% complete response rate for zilovertamab vedotin in diffuse large B-cell lymphoma, new insights into zanubrutinib’s efficacy in chronic lymphocytic leukemia, and promising survival data for belantamab mafodotin in multiple myeloma. Like what you hear? Download Curie from the App Store for more personalized healthcare content.

More episodes of the podcast Curie: Healthcare in Focus

The Preconception Revolution with Dr. Ann Shippy 04/11/2025
From Breakdown to Breakthrough - A Physician’s Reckoning with Burnout 28/10/2025
The Wellness Industrial Complex: What Influencers Reveal About Modern Medicine 21/10/2025
Autopilot Medicine: The Danger of Getting Too Good at AI 14/10/2025
Tylenol & Autism: What Clinicians Should Know (and Watch For) 07/10/2025
Replaceable You – Mary Roach on the Miracles We Can’t Copy 30/09/2025
The Great American Healthcare Heist with Chris Deacon 23/09/2025
From Bedside to Boardroom - Krista Bragg on Bridging Clinician and Executive Perspectives 16/09/2025
AI Scribes – The Hidden Cost of Progress 09/09/2025
Dr. Nasser Hanna - A Life in Medicine, Mentorship, and Advocacy 26/08/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA